AMOIA, PASQUALE
 Distribuzione geografica
Continente #
NA - Nord America 278
EU - Europa 173
AS - Asia 63
AF - Africa 1
OC - Oceania 1
Totale 516
Nazione #
US - Stati Uniti d'America 275
IT - Italia 69
CN - Cina 30
IE - Irlanda 30
SE - Svezia 29
UA - Ucraina 14
IN - India 12
TR - Turchia 12
DE - Germania 10
GB - Regno Unito 7
BE - Belgio 4
CA - Canada 3
FR - Francia 3
PT - Portogallo 3
ES - Italia 2
HK - Hong Kong 2
VN - Vietnam 2
AU - Australia 1
EG - Egitto 1
FI - Finlandia 1
HR - Croazia 1
JP - Giappone 1
PH - Filippine 1
SG - Singapore 1
TH - Thailandia 1
TW - Taiwan 1
Totale 516
Città #
Chandler 80
Ann Arbor 31
Dublin 30
Chieti 28
Jacksonville 26
Dearborn 17
Ashburn 16
Princeton 12
Izmir 11
Altamura 7
Beijing 7
Boardman 5
Hebei 5
Nanchang 5
Nanjing 5
Bosa 4
Brussels 4
Milan 4
Wilmington 4
Lisbon 3
Washington 3
Woodbridge 3
Aquila 2
Dong Ket 2
Fabriano 2
Guelph 2
Hong Kong 2
Kunming 2
Los Angeles 2
Pune 2
Redwood City 2
Shenyang 2
Atlanta 1
Bangkok 1
Bari 1
Cairo 1
Cambridge 1
Changsha 1
Chicago 1
Collecorvino 1
Como 1
Guntur 1
Helsinki 1
Jiaxing 1
Jinan 1
Kocaeli 1
Madrid 1
Manila 1
Napoli 1
New Delhi 1
Ningbo 1
Norwalk 1
Pisa 1
Regensburg 1
Rome 1
San Vito Chietino 1
Seattle 1
State College 1
Staten Island 1
Taipei 1
Tokyo 1
Vaudreuil 1
Zagreb 1
Totale 361
Nome #
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 113
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 88
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 82
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 79
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome 68
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 65
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 56
New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer 15
Totale 566
Categoria #
all - tutte 1.815
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.815


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201930 0 0 0 0 0 0 0 0 0 0 8 22
2019/2020126 23 0 3 4 18 13 10 4 6 29 6 10
2020/202170 4 3 9 2 8 19 2 4 9 2 1 7
2021/202259 1 1 3 11 1 2 1 2 5 0 9 23
2022/2023180 12 29 17 25 15 28 8 15 17 2 10 2
2023/202468 4 4 9 6 7 21 11 1 0 5 0 0
Totale 566